Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | PARP1 | P09874 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | BCAT2 | O15382 | 2/20 | 0.52 |
| ▸ | MKNK1 | Q9BUB5 | 3/20 | 0.51 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.51 |
| ▸ | CHEK2 | O96017 | 4/20 | 0.51 |
| ▸ | DHODH | Q02127 | 2/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30903715 | 1.00 | L3MBTL1 (0.52) | L3MBTL1POLBCYP3A4PARP1MAPT | |
| Hydrochloric Acid SCHEMBL28812686 | 0.98 | CHEK2 (0.50) | L3MBTL1POLBCYP3A4PARP1MAPT | |
| SCHEMBL5307129 | 0.93 | BAZ2B (0.51) | L3MBTL1POLBCYP3A4PARP1MAPT | |
| SCHEMBL22289582 | 0.87 | CHEK2 (0.51) | MAPTMKNK1MKNK2CHEK2DHODH | |
| SCHEMBL944091 | 0.85 | BCAT2 (0.63) | L3MBTL1POLBCYP3A4PARP1MAPT | |
| SCHEMBL3781170 | 0.85 | MKNK1 (0.53) | L3MBTL1POLBCYP3A4PARP1MAPT | |
| SCHEMBL3265708 | 0.85 | BCAT2 (0.63) | L3MBTL1POLBCYP3A4PARP1MAPT | |
| SCHEMBL3788399 | 0.85 | CHEK2 (0.53) | L3MBTL1POLBCYP3A4PARP1MAPT | |
| SCHEMBL16428951 | 0.85 | BACE1 (0.54) | L3MBTL1POLBCYP3A4PARP1MAPT | |
| SCHEMBL36018 | 0.83 | TTR (0.62) | L3MBTL1POLBMAPTTSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025085662-A1 | COMPOUNDS FOR TOCOLYTIC USE | VANDERBILT UNIVERSITY (US) | 2025-04-24 | — | — | WO | disclosed |
| EP-3464319-A2 | INTERMEDIATES AND PROCESSES TO PREPARE ANIDULAFUNGIN | Alaparthi, Lakshmi Prasad (IN) | 2019-04-10 | — | — | EP | disclosed |
| WO-2016056022-A2 | INTERMEDIATES AND PROCESSES TO PREPARE ANIDULAFUNGIN | ALAPARTHI LAKSHMI PRASAD (IN) | 2016-04-14 | — | — | WO | disclosed |
| US-9096600-B2 | N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors | INCYTE CORPORATION (US) | 2015-08-04 | — | — | US | disclosed |
| US-20120157430-A1 | N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS | INCYTE CORPORATION | 2012-06-21 | — | — | US | disclosed |
| WO-2011075747-A1 | THERAPEUTIC COMPOUNDS | GLAXOSMITHKLINE LLC (US) | 2011-06-23 | — | — | WO | disclosed |
| WO-1994027949-A1 | NOVEL HYDROXYBIPHENYL DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | RHONE-POULENC RORER S.A. (FR) | 1994-12-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157430-A1 | N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS | PIK3CA, PIK3CD, PI4KB | L3MBTL1 3068/4885POLB 1091/4885CYP3A4 4255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.